Huang, Jen-Seng , M.D.
Intitution: Keelung Chang Gung Memorial Hospital
Position:
Director/ Instructor / Attending Physician
Department:
Division of Hemato-Oncology
Address:200, Lane 208, Jijin 1st Road, Keelung 20445, Taiwan
Tel:(02)-24329292 ext. 2360 Fax: (02)-24315273 
E-mail: liting@cgmh.org.tw
Focus of Interest:- Medicine, General & Internal
- Oncology
Fulltime Employment: - 1983/9 -- 1986/8 Resident: Department of Internal Medicine, Chang-Gung Memorial Hospital
- 1986/9 -- 1987/8 Chief Resident: Division of Hemato-Oncology, Department of Internal Medicine, Chang-Gung Memorial Hospital
- 1987/9 -- 1988/8 Fellow: Division of Hemato-Oncology, Chang-Gung Memorial Hospital
- 1988/9 -- 1989/11 Attending Physician: Division of Hemato-Oncology, Chang Gung Memorial Hospital (Linko)
- 1989/12 -- Now Attending Physician: Division of Hemato-Oncology, Chang Gung Memorial Hospital (Keelung)
- 1995/7 -- Now Chief of Division of Hemato-Oncology, Chang Gung Memorial Hospital (Keelung)
Education: - Kaohsiung Medical College (1974/10 -- 1981/06)
- Medical Oncology Basic Science Seminar by George Washington University (1987/April to July)
Selected Main Publications:- Yen-Min Huang, Tsung-Han Wu, Cheng-Hsu Wang, Jen-Seng Huang*. Improvement of Bone Metastases of a Case with Female Breast Cancer by Combined Zoledronic Acid Treatment. Journal of Cancer Research and Practice, 2010; 26: 125-132.
- Yen-Min Huang, Cheng-Hsu Wang1, Chung-Chieh Yu, Pei-Hung Chang, Jen-Seng Huang*.Bilateral Reactive Pleural Effusion as a Complication of Picibanil Pleurodesis.台灣癌症醫誌 (Journal of Cancer Research and Practice) 2011, 27(6),268-275
- Pei-Hung Chang, Yen-Min Huang, Yueh-Shih Chang, Cheng-Hsu Wang, Jeng-Seng Huang*.Hypersensitivity Reaction to Oxaliplatin.台灣癌症醫誌 (Journal of Cancer Research and Practice) 2011, 27(5),222-226
- Huang YM, Hsieh TY, Chen JR, Chien HP, Chang PH, Wang CH, Huang JS*.Gastric and colonic metastases from primary lung adenocarcinoma: A case report and review of the literature. Oncol Lett. 2012 Sep;4(3):517-520.
- Chang PH, Huang JS*. Successful rechallenge of cetuximab following severe infusion-related reactions: A case report. Chin J Cancer Res 2014; 26(1): E10-12.
Full Publication List 
Board Certification:1. Chinese License No: 醫字第010907號 (Date: May 29, 1982)
2. Specialist of Internal Medicine 內醫專字第1078號 (Date: June 26, 1988)
3. The Board of Medical Oncology 中腫內專字第79031號 (Date: Nov.14, 1990)
Ongoing projects: Integrating 18F-FDG PET/CT with 18F-FLT PET/CT in predicting treatment response and prognosis of metastatic/recurrent breast cancer